Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia

Leukemia Research

Volumn 33, Issue 7, 2009, Pages 1001-1004

  Park, Tae Sung ^a   Cheong, June Won ^a   Song, Jaewoo ^a   Choi, Jong Rak ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

CLL; Cyclophosphamide; Fludarabine; Rituximab; t MDS

Indexed keywords

AZACITIDINE; CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 17; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; FLOW CYTOMETRY; HUMAN; KARYOTYPE; LYMPHOCYTOSIS; MALE; MONOSOMY 7; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 17; CYTOGENETIC ANALYSIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MONOSOMY; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC;

EID: 66349089334     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.025     Document Type: Article

References (26)

1. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO classification of tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon
2. McPherson R.A., and Pincus M.R. Henry's clinical diagnosis and management by laboratory methods (2007), Saunders, Philadelphia
3. Chena C., Arrossagaray G., Scolnik M., Palacios M.F., and Slavutsky I. Interphase cytogenetic analysis in Argentinean B-cell chronic lymphocytic leukemia patients: association of trisomy 12 and del(13q14). Cancer Genet Cytogenet 146 (2003) 154-160
4. Morrison V.A., Rai K.R., Peterson B.L., Kolitz J.E., Elias L., Appelbaum F.R., et al. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 20 (2002) 3878-3884
5. Schlaifer D., Riga-Huguet F., Pris J., Brousset P., Delannoy A., and Bosly A. Secondary neoplasms in two patients treated with purine analogues. Nouv Rev Fr Hematol 36 (1994) 341
6. Frewin R.J., Provan D., and Smith A.G. Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia. Clin Lab Haematol 19 (1997) 151-152
7. Coso D., Costello R., Cohen-Valensi R., Sainty D., Nezri M., Gastaut J.A., et al. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy. Ann Oncol 10 (1999) 362-363
8. Lam C.C., Ma E.S., and Kwong Y.L. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia. Am J Hematol 79 (2005) 288-290
9. Callea V., Brugiatelli M., Stelitano C., Gentile M., Nobile F., and Morabito F. Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy. Leuk Lymphoma 47 (2006) 2314-2320
10. Shaffer L.G., Tommerup N., and ISCN. An international system for human cytogenetic nomenclature (2005), Karger, Basel
11. Manusow D., and Weinerman B.H. Subsequent neoplasia in chronic lymphocytic leukaemia. JAMA 232 (1975) 267-269
12. Greene M.H., Hoover R.N., and Fraumeni Jr. J.F. Subsequent cancer in patients with chronic lymphocytic leukemia-a possible immunologic mechanism. J Natl Cancer Inst 61 (1978) 337-340
13. Rozman C., and Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 333 (1995) 1052-1057
14. Robertson L.E., Estey E., Kantarjian H., Koller C., O'Brien S., Brown B., et al. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia. Leukemia 8 (1994) 2047-2051
15. Zarrabi M.H., Grünwald H.W., and Rosner F. Chronic lymphocytic leukemia terminating in acute leukemia. Arch Intern Med 137 (1977) 1059-1154
16. Dighiero G., Maloum K., Desablens B., Cazin B., Navarro M., Leblay R., et al. Chlorambucil in indolent chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 338 (1998) 1506-1514
17. Rai K.R., Peterson B.L., Appelbaum F.R., Kolitz J., Elias L., Shepherd L., et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 343 (2000) 1750-1757
18. Karran P., and Attard N. Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 8 (2008) 24-36
19. Kwong Y.L., Au W.Y., and Liang R.H. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: association with -7/7q-. Cancer Genet Cytogenet 104 (1998) 94-97
20. Park TS, Cheong JW, Song J, Lee KA, Lee SG, Kim J, et al. Acute erythroleukemia with der(1;7)(q10;p10) as a sole acquired abnormality after treatment with azathioprine. Cancer Genet Cytogenet 2008; 186:58-60.
21. Offman J., Opelz G., Doehler B., Cummins D., Halil O., Banner N.R., et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 104 (2004) 822-828
22. Krishnan K., Adams P., Silveira S., Sheldon S., and Dabich L. Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis. Clin Lab Haematol 16 (1994) 285-289
23. Cheson B.D., Vena D.A., Barrett J., and Freidlin B. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol 17 (1999) 2454-2460
24. Astrow A.B. Fludarabine-related myeloid leukemia. J Clin Oncol 21 (2003) 3709-3710
25. Abramson J., Verma R.S., and Schwartz J. A new chromosomal abnormality in a patient with acute myelomonocytic leukemia. Oncology 45 (1988) 84-87
26. Secker-Walker L.M., Moorman A.V., Bain B.J., and Mehta A.B. Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop. Leukemia 12 (1998) 840-844